DR. NEIL SANKAR M.D., M.P.H
Dr. Sankar is President and Chief Medical Officer of SwanBio, LLC, a business development consultancy firm that facilitates the translation of scientific discoveries into cancer therapeutics. With over 25 years of experience in healthcare management, he has trained in India, the United Kingdom, the West Indies and the United States, and partnered with leading academic and research institutions all over the world. Dr. Sankar is an expert in global clinical development and regulatory strategies for therapeutic drugs, and has led numerous clinical trials in oncology therapy ranging from breast, ovarian, pancreatic, liver, lung, and connective tissue tumors, to a range of hematological malignancies. His expertise also includes the design and deployment of tools used to evaluate the efficacy and safety of clinical trials. He also played an instrumental role in 3 successful NDA submissions, including 2 blockbuster drugs in oncology. He has also had various publications, posters and abstracts presented at conferences such as The American Society of Clinical Oncology (ASCO) and The American Association for Cancer Research (AACR) conferences. Dr. Sankar is a member of several drug safety committees and advisory boards, including Leukemia Therapeutics and Temple Therapeutics, and is an active member of the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), the European Hematology Association (EHA), Drug Information Association (DIA), European Society of Clinical Oncology (ESMO), American Association for Cancer Research (AACR), Enterprising Pharmaceutical Professionals from the Indian Sub-Continent (EPPIC GLOBAL), Connective Tissue Oncology Society (CTOS), The Indo-American Cancer Association (IACA) and TiE Silicon Valley.